Literature DB >> 9873884

Development of a subdural vein thrombosis following aggressive factor VII replacement for postnatal intracranial haemorrhage in a homozygous factor VII-deficient infant.

L L Worth1, W K Hoots.   

Abstract

Congenital factor VII deficiency is a rare (1:500,000) autosomally recessive coagulopathy with variable expression and high penetration. In infants the most devastating presentation is that of intracranial haemorrhage. An infant is described with severe factor VII deficiency who developed postnatal intracranial haemorrhage. The baby was treated with factor VII concentrate (ImmunoA.G., Vienna, Austria). Three weeks after the haemorrhage he developed a dural venous sinus thrombosis. Although factor VII-deficient patients may need treatment with factor VII concentrate, this needs to be carefully monitored because of the thrombotic risk.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9873884     DOI: 10.1046/j.1365-2516.1998.00181.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  2 in total

Review 1.  Congenital FVII deficiency and thrombotic events after replacement therapy.

Authors:  Antonio Girolami; Irene Bertozzi; Ignazio Rigoni; Rodolfo Muzzolon; Silvia Vettore
Journal:  J Thromb Thrombolysis       Date:  2011-10       Impact factor: 2.300

Review 2.  Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature.

Authors:  A Girolami; F Tezza; R Scandellari; S Vettore; B Girolami
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.